- About Us ▼
- Products ▼
- Pipeline ▼
- Current Vacancies
- Conditions of Sale ▼
- Contact Us ▼
EUSA Pharma is a newly formed specialty pharmaceutical company headquartered in the UK which supplies medicines and medical devices across Europe through its own operations, and worldwide through a network of partners in over 40 countries.
EUSA Pharma Corporate Headquarters for more information on EUSA Pharma.
EUSA Pharma Customer Services for information on how to order all EUSA Pharma products.
EUSA Pharma Medical Information Department for all medical information enquiries.
EUSA Pharma Product Safety to report any safety concerns with any EUSA Pharma product.
HEMEL HEMPSTEAD, England and VIENNA, Austria – 4 October 2016
EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced the acquisition of exclusive global commercialization rights to the oncology product Isqette (dinutuximab beta) from Apeiron Biologics. The immunotherapy has orphan drug designation in the US and EU and is currently under review for marketing authorization by the EMA.
Click here to download the press release (PDF)
HAMILTON, NJ USA – 30 September 2016
If you wish to know more / are eligible / apply, please click here
Please click here to download